|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Total cash | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Prepaid expenses - Short-Term | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Other investments held for trading (Restricted) | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Investments held in the Trust Account | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accrued Tax Payable - Income Tax | ||||||||||||||||||||
| Franchise Tax Payable | ||||||||||||||||||||
| Accrued Tax Payable - Excise Tax | ||||||||||||||||||||
| Franchise Tax Payable Current | ||||||||||||||||||||
| Other accrued expenses - deferred | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Loan payable - Sponsor | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Derivative warrant liabilities | ||||||||||||||||||||
| Deferred underwriting commission | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Class A common stock subject to possible redemption; 513,478 and 516,197 shares at June 30, 2026 and December 31, 2025, respectively – approximately $12.36 and $12.20 per share, respectively | ||||||||||||||||||||
| Stockholders' deficit: | ||||||||||||||||||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | ||||||||||||||||||||
| Common stock value | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Class B common stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders' Deficit | ||||||||||||||||||||
| Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit | ||||||||||||||||||||
Loading...